Welcome to the International Antiviral Society-USA - Washington, DC, Course

Font Size

Optional method to change the font size: hold down <CTRL> and type "+" or "-"

For your convenience, we suggest that you bookmark this page. Additional meeting information will be posted to this Web site, as it is available.

Quick Links: to access program details, click on any link listed below. To return to this page, click on the back button of your browser.

WASHINGTON, DC, COURSE – WEDNESDAY, MAY 4, 2011

Course Chairs:

Henry Masur, MD
Course Chair
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

Michael S. Saag, MD
Course Vice-Chair
Member, Board of Directors (Volunteer)
International Antiviral Society–USA
Professor of Medicine
Jim Straley Chair in AIDS Research
Director, Center for AIDS Research
University of Alabama at Birmingham
Birmingham, Alabama

COURSE OVERVIEW

Assessment of Needs:

Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on strategies for clinical management. Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert faculty of HIV/AIDS clinicians and researchers.

Conflicts of Interest:

Information regarding financial relationships with commercial companies that have interests in the content discussed, is obtained from all parties with control over the activity content (ie, co-chairs, faculty, and IAS–USA staff), and any real or apparent conflicts of interest of those parties are resolved prior to the activity being delivered. Financial affiliations of all those parties are published in the course syllabus. Individuals who refuse to disclose financial interests may not participate in the CME activity.

Who Should Attend:

This course is designed for physicians and other clinical decision makers who are actively involved in the medical care of people with HIV/AIDS, specifically those who:

Have a solid, working knowledge of HIV disease management
Provide comprehensive or specialty care for patients with HIV/AIDS
Are currently active in HIV/AIDS research

This course is relevant for practitioners who are involved in HIV/AIDS patient care, including nurse practitioners and other nursing professionals, physician assistants, pharmacists, and others.

Representatives and employees of commercial companies (pharmaceutical, diagnostic, medical products, advertising, insurance, investment, communications firms, etc) must contact the IAS–USA regarding registration procedures.

GRANT SUPPORT

In the interest of an objective, balanced, and scientifically rigorous CME program, educational grants are pooled to support this activity. We gratefully acknowledge the below commercial companies for their contributions.

MAJOR SUPPORTERS:
Gilead Sciences, Inc
Merck & Co, Inc

SUBSTANTIAL SUPPORTERS:
Bristol-Myers Squibb
Tibotec Therapeutics

GENEROUS SUPPORTER:
Abbott Laboratories
ViiV Healthcare

Requests for additional educational grants have been made to commercial companies with competing products. Information on additional grant supporters will be posted on the IAS–USA Web site as it becomes available.

AGENDA

Washington, DC, Course Agenda (2011)

The agenda is updated on an ongoing basis. Please check back periodically for new information.

SYLLABUS BOOK

For syllabus book, please click here.

KEY SLIDES FROM CONFERENCE LECTURES
Conference speakers selected approximately 15 to 20 key slides from their presentations that they thought would be useful to attendees who are presenting updates from this update to their colleagues.

LEARNING OBJECTIVES

Upon completion of the course, participants will be able to:

Design antiretroviral strategies that consider current data on:

Initial therapy
The role of new and investigational drugs
Antiretroviral regimen failure
Drug-drug interactions

Describe the incidence and management of narcotic addiction in HIV-infected patients
Classify neurocognitive impairment in HIV-infected individuals
Identify and discuss changes to treatment guidelines for sexually transmitted diseases and opportunistic infections
Describe current data on investigational hepatitis C virus drugs as they impact the potential for treatment

CONTINUING MEDICAL EDUCATION INFORMATION

Accreditation:

The IAS–USA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement:

The IAS–USA designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note that nursing continuing education credits are not provided for this course. Nurse practitioners and other nursing professionals will receive a certificate of attendance.

Nursing credits are provided at selected courses. To determine if they are offered for a specific course, please click the corresponding link on the course schedule page and look under "continuing medical education information."

American Academy of Family Physicians Credit:

This live activity, 19th Annual Improving the Management of HIV Disease, with a beginning date of May 4, 2011, has been reviewed and is acceptable for up to 6.25 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

REGISTRATION INFORMATION, DEADLINES, AND FEES

Save time and register online with secure credit card payment. You may also download and mail or fax in a completed registration form and payment.

The registration fee is $60 on or before April 13, and will increase to $80 after April 13. Early registration is strongly recommended. Preregistration closes on April 27.

Incomplete applications (missing information, unchecked boxes, no payment included) will be returned for completion, prior to processing. If you have not registered or have not received registration confirmation 2 weeks prior to the course, please contact us to confirm that seating is still available.

Registered attendees may access the course syllabus, in PDF format, on our Web site after April 27. Please note: The syllabus is typically more than 100 pages long and may take extra time to download. Please submit requests for cancellation or substitution in writing to the IAS–USA office by April 20.

Contact the IAS–USA:
425 California Street Suite 1450
San Francisco, CA 94104-2120
Phone: (415) 544-9400
Fax: (415) 544-9401

Register online: https://www.iasusa.org/register.php
Download a registration form: http://www.iasusa.org/registration/form/2011/swashington.pdf

HOTEL, TRAVEL, AND GENERAL MEETING INFORMATION

For general venue information, including directions and parking, please click here.